Tags

Type your tag names separated by a space and hit enter

Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study.
Lancet Diabetes Endocrinol. 2015 Jan; 3(1):35-42.LD

Abstract

BACKGROUND

Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, are associated with an increased risk of type 2 diabetes, but whether this association is causal remains unclear. We aimed to estimate the unconfounded, causal association between 25(OH)D concentration and risk of type 2 diabetes using a mendelian randomisation approach.

METHODS

Using several data sources from populations of European descent, including type 2 diabetes cases and non-cases, we did a mendelian randomisation analysis using single nucleotide polymorphisms (SNPs) within or near four genes related to 25(OH)D synthesis and metabolism: DHCR7 (related to vitamin D synthesis), CYP2R1 (hepatic 25-hydroxylation), DBP (also known as GC; transport), and CYP24A1 (catabolism). We assessed each SNP for an association with circulating 25(OH)D concentration (5449 non-cases; two studies), risk of type 2 diabetes (28 144 cases, 76 344 non-cases; five studies), and glycaemic traits (concentrations of fasting glucose, 2-h glucose, fasting insulin, and HbA1c; 46 368 non-cases; study consortium). We combined these associations in a likelihood-based mendelian randomisation analysis to estimate the causal association of 25(OH)D concentration with type 2 diabetes and the glycaemic traits, and compared them with that from a meta-analysis of data from observational studies (8492 cases, 89 698 non-cases; 22 studies) that assessed the association between 25(OH)D concentration and type 2 diabetes.

FINDINGS

All four SNPs were associated with 25(OH)D concentrations (p<10(-6)). The mendelian randomisation-derived unconfounded odds ratio for type 2 diabetes was 1·01 (95% CI 0·75-1·36; p=0·94) per 25·0 nmol/L (1 SD) lower 25(OH)D concentration. The corresponding (potentially confounded) relative risk from the meta-analysis of data from observational studies was 1·21 (1·16-1·27; p=7·3 × 10(-19)). The mendelian randomisation-derived estimates for glycaemic traits were not significant (p>0·25).

INTERPRETATION

The association between 25(OH)D concentration and type 2 diabetes is unlikely to be causal. Efforts to increase 25(OH)D concentrations might not reduce the risk of type 2 diabetes as would be expected on the basis of observational evidence. These findings warrant further investigations to identify causal factors that might increase 25(OH)D concentration and also reduce the risk of type 2 diabetes.

FUNDING

UK Medical Research Council Epidemiology Unit and European Union Sixth Framework Programme.

Authors+Show Affiliations

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.No affiliation info availableMRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK. Electronic address: nita.forouhi@mrc-epid.cam.ac.uk.

Pub Type(s)

Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25281353

Citation

Ye, Zheng, et al. "Association Between Circulating 25-hydroxyvitamin D and Incident Type 2 Diabetes: a Mendelian Randomisation Study." The Lancet. Diabetes & Endocrinology, vol. 3, no. 1, 2015, pp. 35-42.
Ye Z, Sharp SJ, Burgess S, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2015;3(1):35-42.
Ye, Z., Sharp, S. J., Burgess, S., Scott, R. A., Imamura, F., Langenberg, C., Wareham, N. J., & Forouhi, N. G. (2015). Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. The Lancet. Diabetes & Endocrinology, 3(1), 35-42. https://doi.org/10.1016/S2213-8587(14)70184-6
Ye Z, et al. Association Between Circulating 25-hydroxyvitamin D and Incident Type 2 Diabetes: a Mendelian Randomisation Study. Lancet Diabetes Endocrinol. 2015;3(1):35-42. PubMed PMID: 25281353.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. AU - Ye,Zheng, AU - Sharp,Stephen J, AU - Burgess,Stephen, AU - Scott,Robert A, AU - Imamura,Fumiaki, AU - ,, AU - Langenberg,Claudia, AU - Wareham,Nicholas J, AU - Forouhi,Nita G, Y1 - 2014/09/30/ PY - 2014/10/5/entrez PY - 2014/10/5/pubmed PY - 2016/2/13/medline SP - 35 EP - 42 JF - The lancet. Diabetes & endocrinology JO - Lancet Diabetes Endocrinol VL - 3 IS - 1 N2 - BACKGROUND: Low circulating concentrations of 25-hydroxyvitamin D (25[OH]D), a marker of vitamin D status, are associated with an increased risk of type 2 diabetes, but whether this association is causal remains unclear. We aimed to estimate the unconfounded, causal association between 25(OH)D concentration and risk of type 2 diabetes using a mendelian randomisation approach. METHODS: Using several data sources from populations of European descent, including type 2 diabetes cases and non-cases, we did a mendelian randomisation analysis using single nucleotide polymorphisms (SNPs) within or near four genes related to 25(OH)D synthesis and metabolism: DHCR7 (related to vitamin D synthesis), CYP2R1 (hepatic 25-hydroxylation), DBP (also known as GC; transport), and CYP24A1 (catabolism). We assessed each SNP for an association with circulating 25(OH)D concentration (5449 non-cases; two studies), risk of type 2 diabetes (28 144 cases, 76 344 non-cases; five studies), and glycaemic traits (concentrations of fasting glucose, 2-h glucose, fasting insulin, and HbA1c; 46 368 non-cases; study consortium). We combined these associations in a likelihood-based mendelian randomisation analysis to estimate the causal association of 25(OH)D concentration with type 2 diabetes and the glycaemic traits, and compared them with that from a meta-analysis of data from observational studies (8492 cases, 89 698 non-cases; 22 studies) that assessed the association between 25(OH)D concentration and type 2 diabetes. FINDINGS: All four SNPs were associated with 25(OH)D concentrations (p<10(-6)). The mendelian randomisation-derived unconfounded odds ratio for type 2 diabetes was 1·01 (95% CI 0·75-1·36; p=0·94) per 25·0 nmol/L (1 SD) lower 25(OH)D concentration. The corresponding (potentially confounded) relative risk from the meta-analysis of data from observational studies was 1·21 (1·16-1·27; p=7·3 × 10(-19)). The mendelian randomisation-derived estimates for glycaemic traits were not significant (p>0·25). INTERPRETATION: The association between 25(OH)D concentration and type 2 diabetes is unlikely to be causal. Efforts to increase 25(OH)D concentrations might not reduce the risk of type 2 diabetes as would be expected on the basis of observational evidence. These findings warrant further investigations to identify causal factors that might increase 25(OH)D concentration and also reduce the risk of type 2 diabetes. FUNDING: UK Medical Research Council Epidemiology Unit and European Union Sixth Framework Programme. SN - 2213-8595 UR - https://www.unboundmedicine.com/medline/citation/25281353/Association_between_circulating_25_hydroxyvitamin_D_and_incident_type_2_diabetes:_a_mendelian_randomisation_study_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2213-8587(14)70184-6 DB - PRIME DP - Unbound Medicine ER -